DAMORA THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $6.1M | $171.6M | $163.6M |
| FY2021 | $5.0M | $122.2M | $62.6M |
| FY2022 | $11.4M | $73.2M | $32.8M |
| FY2023 | $5.9M | $38.2M | $21.5M |
| FY2024 | $1.3M | $17.1M | $14.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $6.1M | $171.6M | $163.6M |
| FY2021 | $5.0M | $122.2M | $62.6M |
| FY2022 | $11.4M | $73.2M | $32.8M |
| FY2023 | $5.9M | $38.2M | $21.5M |
| FY2024 | $1.3M | $17.1M | $14.2M |